Search

HCV NAT+/- in Thoracic Organ Transplantation: Where Are We Now and What's Next?

Wednesday, May 20, 2020 - 14:00 to 15:00

VIEW ARCHIVE

Speakers:
Kelly Schlendorf, MD, MHS • Assistant Professor of Medicine, Vanderbilt Heart and Vascular Institute, Nashville, TN
Marcelo Cypel MD, MSc, FACS, FRCSC • Associate Professor of Surgery, University of Toronto (UHN), Toronto, ON

Moderator:
Daniel Kaul, MD • Professor of Internal Medicine, University of Michigan, Ann Arbor, MI

After participating in this webinar, the attendee will be able to:

  1. Understand the evolution of and current state of knowledge using HCV donors (NAT+/-) for heart transplantation
  2. Understand the evolution of and current state of knowledge using HCV donors (NAT+/-) for lung transplantation
  3. Describe future directions for utilization of HCV donors (NAT+/-) for thoracic organ transplantation
- - - - -

AST would like to thank the Infectious Disease (IDCOP), Kidney Pancreas (KPCOP), and Liver and Intestinal (LICOP) Communities of Practice for each recommending "HCV" as a topic for the 2019-2020 T3 series. The concept was expanded into two HCV NAT+/- sessions, one covering "HCV NAT+/- in Abdominal Organ Transplantation" and another covering "HCV NAT+/- in Thoracic Organ Transplantation." Learn more about AST's COPs at www.myast.org/cops.

Series: 
Timely Topics in Transplantation Webinar Series
Education Category: 
Heart
Lung
Series category: 
T3: Timely Topics in Transplantion

Donate

Donate

Donate

to the American Society of Transplantation

Career Center

Career Center

Career Center

Connecting Transplantation Talent with Opportunities

Patient Education

Patient Education

Educating the Community

The AST initiative, Power2Save, has great resources for patients and patient families.